Vani Vannappagari

机构：University of North Carolina at Chapel Hill, Goethe University Frankfurt, ViiV Healthcare (Spain) · ORCID：0000-0002-0157-9689

发表论文 120 篇 · 总被引 2369 次 · h-index 23

代表论文

• Integrase Strand Transfer Inhibitor–Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium (2024 · Clinical Infectious Diseases · 被引 29)
• Preferences for Starting Daily, On-Demand, and Long-Acting Injectable HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in the United States (2021-2022): Nationwide Online Cross-Sectional Study (2024 · JMIR Public Health and Surveillance · 被引 12)
• Risk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort (2025 · Clinical Infectious Diseases · 被引 11)
• Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States (2024 · AIDS Research and Therapy · 被引 7)
• Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort (2025 · AJPM Focus · 被引 6)
• Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review (2024 · Infectious Diseases and Therapy · 被引 5)